| The suppressive effect of Rho kinase inhibitor, Y-27632, on oncogenic Ras/RhoA induced invasion/migration of human bladder cancer TSGH cells. | bladder, |
| Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition. | None |
| Activation of Rho is required for ligand-independent oncogenic signaling by a mutant epidermal growth factor receptor. | None |
| Oncogenic Ras leads to Rho activation by activating the mitogen-activated protein kinase pathway and decreasing Rho-GTPase-activating protein activity. | None |
| Active Rho is localized to podosomes induced by oncogenic Src and is required for their assembly and function. | None |
| c-Jun kinase mediates expression of VEGF induced at transcriptional level by Rac1 and Cdc42Hs but not by RhoA. | None |
| Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. | None |
| Critical role of Rho in cell transformation by oncogenic Ras. | None |